Biomerica (BMRA) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 9.73% |
| Nov 30, 2025 | 4.33% |
| Aug 31, 2025 | 7.56% |
| May 31, 2025 | -21.35% |
| Feb 28, 2025 | -5.75% |
| Nov 30, 2024 | -15.19% |
| Aug 31, 2024 | -21.84% |
| May 31, 2024 | 23.19% |
| Feb 29, 2024 | -23.11% |
| Nov 30, 2023 | -27.04% |
| Aug 31, 2023 | -22.06% |
| May 31, 2023 | -23.30% |
| Feb 28, 2023 | -38.60% |
| Nov 30, 2022 | -41.98% |
| Aug 31, 2022 | -55.73% |
| May 31, 2022 | -37.96% |
| Feb 28, 2022 | 19.49% |
| Nov 30, 2021 | -38.77% |
| Aug 31, 2021 | -87.98% |
| May 31, 2021 | -44.66% |
| Feb 28, 2021 | -51.75% |
| Nov 30, 2020 | -52.19% |
| Aug 31, 2020 | -85.10% |
| May 31, 2020 | 24.26% |
| Feb 29, 2020 | -46.51% |
| Nov 30, 2019 | -14.41% |
| Aug 31, 2019 | -17.85% |
| May 31, 2019 | 108.06% |
| Feb 28, 2019 | -88.32% |
| Nov 30, 2018 | -14.45% |
| Aug 31, 2018 | -21.22% |
| May 31, 2018 | -15.58% |
| Feb 28, 2018 | -38.51% |
| Nov 30, 2017 | -25.93% |
| Aug 31, 2017 | -22.19% |
| May 31, 2017 | -51.21% |
| Feb 28, 2017 | -34.26% |
| Nov 30, 2016 | -25.64% |
| Aug 31, 2016 | -20.70% |
| May 31, 2016 | -77.49% |
| Feb 29, 2016 | -41.57% |
| Nov 30, 2015 | -3.38% |